Shuttle Pharmaceuticals Holdings (SHPH) Operating Expenses (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Operating Expenses history runs 6 years deep, the most recent figure standing at $2.2 million for Q1 2026.

• On a quarterly basis, Operating Expenses fell 24.89% year-over-year to $2.2 million in Q1 2026; TTM through Mar 2026 was $11.9 million, a 28.41% increase from a year earlier, with the FY2025 full-year figure at $11.9 million, up 54.84% from the prior year.
• Operating Expenses retreated to $2.2 million in Q1 2026 per SHPH's latest filing, from $3.5 million in the prior quarter.
• Across five years, Operating Expenses topped out at $3.9 million in Q2 2025 and bottomed at $353626.0 in Q2 2022.
• The 5-year median for Operating Expenses is $1.5 million (2023), against an average of $1.8 million.
• Across the five-year window, Operating Expenses tumbled 46.35% in 2022 and surged 314.46% in 2023, its largest moves.
• Year by year, Operating Expenses stood at $530336.0 in 2022, then jumped by 141.89% to $1.3 million in 2023, then soared by 38.53% to $1.8 million in 2024, then surged by 96.95% to $3.5 million in 2025, then plunged by 36.66% to $2.2 million in 2026.
• Per Business Quant, the three latest SHPH Operating Expenses figures stand at $2.2 million (Q1 2026), $3.5 million (Q4 2025), and $2.3 million (Q3 2025).